 | • レポートコード：QYR9ST04731 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、出血性疾患の世界市場について調査・分析し、出血性疾患の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他）、用途別（血友病A、血友病B、フォン・ヴィレブランド病、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の出血性疾患市場動向 ・主要企業別マーケットシェア ・出血性疾患の種類別市場規模2014-2019 （血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他） ・出血性疾患の用途別市場規模2014-2019 （血友病A、血友病B、フォン・ヴィレブランド病、その他） ・出血性疾患の北米市場：主要企業・種類別/用途別市場規模 ・出血性疾患のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・出血性疾患の中国市場：主要企業・種類別/用途別市場規模 ・出血性疾患の日本国内市場：主要企業・種類別/用途別市場規模 ・出血性疾患の東南アジア市場：主要企業・種類別/用途別市場規模 ・出血性疾患のインド市場：主要企業・種類別/用途別市場規模 ・出血性疾患の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Novo Nordisk、Bayer、Baxter International、Alnylam Pharmaceuticals、Pfizer、Xenetic Biosciences、Bristol-Myers Squibb Company、Sanofi、Janssen Global Services、Bioverativ、Amgen） ・出血性疾患の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.In 2018, the global Bleeding Disorders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bleeding Disorders status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bleeding Disorders development in United States, Europe and China.
The key players covered in this study
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Market segment by Type, the product can be split into
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Market segment by Application, split into
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bleeding Disorders status, future forecast, growth opportunity, key market and key players.
To present the Bleeding Disorders development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bleeding Disorders are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bleeding Disorders Market Size Growth Rate by Type (2014-2025)
1.4.2 Plasma-derived Coagulation Factor Concentrates
1.4.3 Recombinant Coagulation Factor Concentrates
1.4.4 Desmopressin
1.4.5 Antifibrinolytics
1.4.6 Fibrin Sealants
1.4.7 Others
1.5 Market by Application
1.5.1 Global Bleeding Disorders Market Share by Application (2014-2025)
1.5.2 Hemophilia A
1.5.3 Hemophilia B
1.5.4 Von Willebrand Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bleeding Disorders Market Size
2.2 Bleeding Disorders Growth Trends by Regions
2.2.1 Bleeding Disorders Market Size by Regions (2014-2025)
2.2.2 Bleeding Disorders Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bleeding Disorders Market Size by Manufacturers
3.1.1 Global Bleeding Disorders Revenue by Manufacturers (2014-2019)
3.1.2 Global Bleeding Disorders Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bleeding Disorders Market Concentration Ratio (CR5 and HHI)
3.2 Bleeding Disorders Key Players Head office and Area Served
3.3 Key Players Bleeding Disorders Product/Solution/Service
3.4 Date of Enter into Bleeding Disorders Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bleeding Disorders Market Size by Type (2014-2019)
4.2 Global Bleeding Disorders Market Size by Application (2014-2019)
5 United States
5.1 United States Bleeding Disorders Market Size (2014-2019)
5.2 Bleeding Disorders Key Players in United States
5.3 United States Bleeding Disorders Market Size by Type
5.4 United States Bleeding Disorders Market Size by Application
6 Europe
6.1 Europe Bleeding Disorders Market Size (2014-2019)
6.2 Bleeding Disorders Key Players in Europe
6.3 Europe Bleeding Disorders Market Size by Type
6.4 Europe Bleeding Disorders Market Size by Application
7 China
7.1 China Bleeding Disorders Market Size (2014-2019)
7.2 Bleeding Disorders Key Players in China
7.3 China Bleeding Disorders Market Size by Type
7.4 China Bleeding Disorders Market Size by Application
8 Japan
8.1 Japan Bleeding Disorders Market Size (2014-2019)
8.2 Bleeding Disorders Key Players in Japan
8.3 Japan Bleeding Disorders Market Size by Type
8.4 Japan Bleeding Disorders Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bleeding Disorders Market Size (2014-2019)
9.2 Bleeding Disorders Key Players in Southeast Asia
9.3 Southeast Asia Bleeding Disorders Market Size by Type
9.4 Southeast Asia Bleeding Disorders Market Size by Application
10 India
10.1 India Bleeding Disorders Market Size (2014-2019)
10.2 Bleeding Disorders Key Players in India
10.3 India Bleeding Disorders Market Size by Type
10.4 India Bleeding Disorders Market Size by Application
11 Central & South America
11.1 Central & South America Bleeding Disorders Market Size (2014-2019)
11.2 Bleeding Disorders Key Players in Central & South America
11.3 Central & South America Bleeding Disorders Market Size by Type
11.4 Central & South America Bleeding Disorders Market Size by Application
12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bleeding Disorders Introduction
12.1.4 Novo Nordisk Revenue in Bleeding Disorders Business (2014-2019)
12.1.5 Novo Nordisk Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bleeding Disorders Introduction
12.2.4 Bayer Revenue in Bleeding Disorders Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Baxter International
12.3.1 Baxter International Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bleeding Disorders Introduction
12.3.4 Baxter International Revenue in Bleeding Disorders Business (2014-2019)
12.3.5 Baxter International Recent Development
12.4 Alnylam Pharmaceuticals
12.4.1 Alnylam Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bleeding Disorders Introduction
12.4.4 Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2014-2019)
12.4.5 Alnylam Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bleeding Disorders Introduction
12.5.4 Pfizer Revenue in Bleeding Disorders Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Xenetic Biosciences
12.6.1 Xenetic Biosciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bleeding Disorders Introduction
12.6.4 Xenetic Biosciences Revenue in Bleeding Disorders Business (2014-2019)
12.6.5 Xenetic Biosciences Recent Development
12.7 Bristol-Myers Squibb Company
12.7.1 Bristol-Myers Squibb Company Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bleeding Disorders Introduction
12.7.4 Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2014-2019)
12.7.5 Bristol-Myers Squibb Company Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Bleeding Disorders Introduction
12.8.4 Sanofi Revenue in Bleeding Disorders Business (2014-2019)
12.8.5 Sanofi Recent Development
12.9 Janssen Global Services
12.9.1 Janssen Global Services Company Details
12.9.2 Company Description and Business Overview
12.9.3 Bleeding Disorders Introduction
12.9.4 Janssen Global Services Revenue in Bleeding Disorders Business (2014-2019)
12.9.5 Janssen Global Services Recent Development
12.10 Bioverativ
12.10.1 Bioverativ Company Details
12.10.2 Company Description and Business Overview
12.10.3 Bleeding Disorders Introduction
12.10.4 Bioverativ Revenue in Bleeding Disorders Business (2014-2019)
12.10.5 Bioverativ Recent Development
12.11 Amgen
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bleeding Disorders Key Market Segments
Table Key Players Bleeding Disorders Covered
Table Global Bleeding Disorders Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bleeding Disorders Market Size Market Share by Type 2014-2025
Figure Plasma-derived Coagulation Factor Concentrates Figures
Table Key Players of Plasma-derived Coagulation Factor Concentrates
Figure Recombinant Coagulation Factor Concentrates Figures
Table Key Players of Recombinant Coagulation Factor Concentrates
Figure Desmopressin Figures
Table Key Players of Desmopressin
Figure Antifibrinolytics Figures
Table Key Players of Antifibrinolytics
Figure Fibrin Sealants Figures
Table Key Players of Fibrin Sealants
Figure Others Figures
Table Key Players of Others
Table Global Bleeding Disorders Market Size Growth by Application 2014-2025 (Million US$)
Figure Hemophilia A Case Studies
Figure Hemophilia B Case Studies
Figure Von Willebrand Disease Case Studies
Figure Others Case Studies
Figure Bleeding Disorders Report Years Considered
Table Global Bleeding Disorders Market Size 2014-2025 (Million US$)
Figure Global Bleeding Disorders Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bleeding Disorders Market Size by Regions 2014-2025 (Million US$)
Table Global Bleeding Disorders Market Size by Regions 2014-2019 (Million US$)
Table Global Bleeding Disorders Market Share by Regions 2014-2019
Figure Global Bleeding Disorders Market Share by Regions 2014-2019
Figure Global Bleeding Disorders Market Share by Regions 2019
Table Market Top Trends
Table Global Bleeding Disorders Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bleeding Disorders Market Share by Manufacturers (2014-2019)
Figure Global Bleeding Disorders Market Share by Manufacturers in 2018
Table Global Bleeding Disorders Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bleeding Disorders Product/Solution/Service
Table Date of Enter into Bleeding Disorders Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table Global Bleeding Disorders Market Size Share by Type (2014-2019)
Figure Global Bleeding Disorders Market Size Market Share by Type (2014-2019)
Table Global Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table Global Bleeding Disorders Market Size Share by Application (2014-2019)
Figure Global Bleeding Disorders Market Size Market Share by Application (2014-2019)
Figure Global Bleeding Disorders Revenue Market Share by Application in 2018
Figure United States Bleeding Disorders Market Size 2014-2019 (Million US$)
Table United States Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table United States Key Players Bleeding Disorders Market Share (2018-2019)
Table United States Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table United States Bleeding Disorders Market Share by Type (2014-2019)
Table United States Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table United States Bleeding Disorders Market Share by Application (2014-2019)
Figure Europe Bleeding Disorders Market Size 2014-2019 (Million US$)
Table Europe Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table Europe Key Players Bleeding Disorders Market Share (2018-2019)
Table Europe Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table Europe Bleeding Disorders Market Share by Type (2014-2019)
Table Europe Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table Europe Bleeding Disorders Market Share by Application (2014-2019)
Figure China Bleeding Disorders Market Size 2014-2019 (Million US$)
Table China Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table China Key Players Bleeding Disorders Market Share (2018-2019)
Table China Bleeding Disorders Market Size by Type (2014-20189) (Million US$)
Table China Bleeding Disorders Market Share by Type (2014-2019)
Table China Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table China Bleeding Disorders Market Share by Application (2014-2019)
Figure Japan Bleeding Disorders Market Size 2014-2019 (Million US$)
Table Japan Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table Japan Key Players Bleeding Disorders Market Share (2018-2019)
Table Japan Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table Japan Bleeding Disorders Market Share by Type (2014-2019)
Table Japan Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table Japan Bleeding Disorders Market Share by Application (2014-2019)
Figure Southeast Asia Bleeding Disorders Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bleeding Disorders Market Share (2018-2019)
Table Southeast Asia Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bleeding Disorders Market Share by Type (2014-2019)
Table Southeast Asia Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bleeding Disorders Market Share by Application (2014-2019)
Figure India Bleeding Disorders Market Size 2014-2019 (Million US$)
Table India Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table India Key Players Bleeding Disorders Market Share (2018-2019)
Table India Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table India Bleeding Disorders Market Share by Type (2014-2019)
Table India Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table India Bleeding Disorders Market Share by Application (2014-2019)
Figure Central & South America Bleeding Disorders Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bleeding Disorders Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bleeding Disorders Market Share (2018-2019)
Table Central & South America Bleeding Disorders Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bleeding Disorders Market Share by Type (2014-2019)
Table Central & South America Bleeding Disorders Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bleeding Disorders Market Share by Application (2014-2019)
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Bleeding Disorders Business (2014-2019) (Million US$)
Figure Novo Nordisk Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Novo Nordisk Recent Development
Table Bayer Company Details
Table Bayer Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Bayer Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Baxter International Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Baxter International Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Alnylam Pharmaceuticals Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Alnylam Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Pfizer Recent Development
Table Xenetic Biosciences Company Details
Table Xenetic Biosciences Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Xenetic Biosciences Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Xenetic Biosciences Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Sanofi Recent Development
Table Janssen Global Services Company Details
Table Janssen Global Services Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Janssen Global Services Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Janssen Global Services Recent Development
Table Bioverativ Company Details
Table Bioverativ Revenue in Bleeding Disorders Business (2014-2019)(Million US$)
Figure Bioverativ Revenue Growth Rate in Bleeding Disorders Business (2014-2019)
Table Bioverativ Recent Development
Table Amgen Company Details
Table Global Bleeding Disorders Market Size by Regions (Million US$) 2019-2025
Figure Global Bleeding Disorders Market Size Share by Regions (2019-2025)
Figure Global Bleeding Disorders Market Size Share by Regions in 2025
Figure United States Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Figure China Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Figure India Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bleeding Disorders Market Size Forecast (2019-2025)(Million USD)
Table Global Bleeding Disorders Market Size by Product (2019-2025) (Million US$)
Figure Global Bleeding Disorders Market Size by Product (2019-2025)
Figure Global Bleeding Disorders Market Size by Product in 2025
Table Global Bleeding Disorders Market Size by Application (2019-2025) (Million US$)
Figure Global Bleeding Disorders Market Size by Application (2019-2025)
Figure Global Bleeding Disorders Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…- 組換え凝固因子の世界市場：市場規模・現状・予測 Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.In 2018, the global Recombinant Coagulation …
- 組換え凝固因子の世界市場：市場規模・現状・予測 Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.In 2018, the global Recombinant Coagulation …
- 因子IX欠乏症の治療の世界市場：市場規模・現状・予測 Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market duri…
- 第VIII因子欠乏症の治療の世界市場：市場規模・現状・予測 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…